News
RMD
196.94
+1.97%
3.80
Weekly Report: what happened at RMD last week (0601-0605)?
Weekly Report · 1d ago
Top 50 High-Quality Dividend Growth Stocks For June 2026
Seeking Alpha · 1d ago
Notable healthcare headlines for the week: UnitedHealth, Medtronic, and Eli Lilly in focus
Seeking Alpha · 2d ago
ResMed (RMD) Valuation Check After Q3 FY2026 Results And Sleep Apnea Demand Update
Simply Wall St · 4d ago
Bank of America Securities Sticks to Its Buy Rating for Resmed (RMD)
TipRanks · 5d ago
Ord Minnett Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
TipRanks · 5d ago
Early notable gainers among liquid option names on June 3rd
TipRanks · 6d ago
ResMed Acquires Sleep-Related Wearables Developer Noctrix Health From Angelini Industries For $340M
Benzinga · 6d ago
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Vera Therapeutics (VERA) and Resmed (RMD)
TipRanks · 6d ago
Is It Time To Reassess ResMed (RMD) After This Year’s 25% Share Price Slide
Simply Wall St · 06/02 23:26
ResMed Completes Acquisition Of Noctrix Health, Expands Sleep Health Portfolio
NASDAQ · 06/02 07:51
Weekly Report: what happened at RMD last week (0525-0529)?
Weekly Report · 06/01 10:09
Wells Fargo Keeps Their Hold Rating on Resmed (RMD)
TipRanks · 06/01 01:21
ResMed And Oura Link Consumer Sleep Data To Clinical Care Pathways
Simply Wall St · 05/31 18:08
Notable healthcare headlines for the week: UnitedHealthcare, Pfizer, Eli Lilly in focus
Seeking Alpha · 05/31 13:05
Weekly Report: what happened at RMD last week (0518-0522)?
Weekly Report · 05/25 10:12
How ResMed–Oura Wearable Sleep Data Partnership Could Reshape ResMed's (RMD) Clinical Ecosystem
Simply Wall St · 05/22 03:35
ResMed (RMD) Valuation Check After Recent Share Price Weakness
Simply Wall St · 05/20 08:31
Silver Economy Investing: Why the Healthcare Giants Are in Focus
NASDAQ · 05/19 19:00
ResMed Targets Circadian Data With New Wearable Trial: What Investors Should Watch
TipRanks · 05/19 16:30
More
Webull provides a variety of real-time RMD stock news. You can receive the latest news about Resmed through multiple platforms. This information may help you make smarter investment decisions.
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.